SAHPRA CEO: No Blanket Prohibition on Section 21, Applications Considered on Merit

SAHPRA’s CEO, Dr Boitumelo Semete-Makokotlela says the regulator does not authorize retail sales of cannabis and will soon clarify the situation around Section 21 access. In the meantime, she says properly backed-up applications for cannabis prescriptions under Section 21 will be considered,
SAHPRA on Section 21: ‘The System Has Been Abused and Will be Reviewed’

SAHPRA says confirmed that the Section 21 medical cannabis access system is under review and most authorizations have been halted. Senior official Daphne Fafudi says genuine medical cannabis patients will be still be accommodated under the current system.
Is This for Real? Canadian Company Launches ‘Odourless’ Cannabis Strain

Canadian company CannabCo has launched ‘Odourless OG’, a cannabis strain that does not have the distinctive ‘weed smell’ that is off-putting to many consumers. Ontario retailers have been quick to pick up on its novelty just months after the strain hit the market.
Track and Trace the Missing Link in Putting South Africa’s New Cannabis Framework in Place

As cannabis evolves into a commodity with multiple end uses, compliance will have to factor in how the plant – or products derived therefrom – move across various regulatory pathways.
H3’s Charl Botha writes that ‘track and trace’ is the missing link needed to sew disparate frameworks together.